Skip to main content

Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity

Mounjaro, the brand-new Type 2 diabetes therapy, brought in $187.3 million in sales in its first full quarter on the market
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.